Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Merck is scheduled to report first-quarter 2026 earnings on April 30 before the market open, with consensus calling for $15.90 billion in revenue and a loss of $1.51 per share. The article is purely an earnings preview and provides no operational update beyond analyst estimates, making the signal mildly negative but largely informational.

Analysis

Merck is scheduled to report first-quarter 2026 earnings on April 30 before the market open, with consensus calling for $15.90 billion in revenue and a loss of $1.51 per share. The article is purely an earnings preview and provides no operational update beyond analyst estimates, making the signal mildly negative but largely informational.